The effect of the stromal component of breast tumours on prediction of clinical outcome using gene expression microarray analysis
-
* Corresponding author: Susan J Cleator s.cleator@imperial.ac.uk
Breast Cancer Research 2006, 8:R32 doi:10.1186/bcr1506
Accesses
- Last 30 days: 55 accesses
- Last year: 625 accesses
- All time: 4627 accesses
Cited by
BioMed Central: 4 citations
|
Fathi Elloumi, Zhiyuan Hu, Yan Li, Joel S Parker, Margaret L Gulley, Keith D Amos, Melissa A Troester BMC Medical Genomics 2011, 4:54 (30 June 2011) |
|
Pierre-Emmanuel Colombo, Fernanda Milanezi, Britta Weigelt, Jorge S Reis-Filho Breast Cancer Research 2011, 13:212 (27 June 2011) In this review, the authors examine the clinical relevance of microarray-based profiling of breast cancer and discuss its impact on patient management.
|
|
Evaluation of the current knowledge limitations in breast cancer research: a gap analysis Alastair Thompson, Keith Brennan, Angela Cox, Julia Gee, Diana Harcourt, Adrian Harris, Michelle Harvie, Ingunn Holen, Anthony Howell, Robert Nicholson, Michael Steel, Charles Streuli, Breast Cancer Research 2008, 10:R26 (27 March 2008) A comprehensive review of the seven main research areas by 56 experts has identified the key gaps and priorities for the greatest potential impact on breast cancer patients.
|
|
Molecular response to aromatase inhibitor treatment in primary breast cancer Alan Mackay, Ander Urruticoechea, J Michael Dixon, Tim Dexter, Kerry Fenwick, Alan Ashworth, Suzanne Drury, Alexey Larionov, Oliver Young, Sharon White, William R Miller, Dean B Evans, Mitch Dowsett Breast Cancer Research 2007, 9:R37 (7 June 2007) |